Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.000
-0.050 (-2.44%)
At close: Sep 11, 2026, 4:00 PM EDT
2.030
+0.030 (1.50%)
After-hours: Sep 11, 2026, 7:58 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $360.18 million as of September 11, 2026. Its market cap has decreased by -40.36% in one year.
Market Cap
360.18M
Enterprise Value
189.93M
1-Year Change
-40.36%
Ranking
Category
Stock Price
$2.00
ChartMarket Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $360.18M, a decrease of -17.27%. That is a compound annual growth rate of -3.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 360.18M | -62.29% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 369.08M |
| Orchestra BioMed Holdings | 367.84M |
| Rocket Pharmaceuticals | 367.74M |
| EyePoint | 364.68M |
| Palisade Bio | 359.00M |
| Sionna Therapeutics | 354.92M |
| Century Therapeutics | 351.29M |
| DiaMedica Therapeutics | 348.90M |